Association of CFTR Mutations and Borderline Sweat Tests

Parad, Richard B.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 5K08DK002273-04
• Application #: 2134133
• Study Section: Special Emphasis Panel (ZHL1-CCT-M (F1))
• Project Start: 1993-07-01
• Project End: 1998-06-30
• Budget Start: 1996-07-01
• Budget End: 1997-06-30
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: Children's Hospital Boston
• DUNS #: 076593722
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02115

Publications

Parad, R B; Gerard, C J; Zurakowski, D et al. (1999) Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun 67:4744-50

Chiba-Falek, O; Parad, R B; Kerem, E et al. (1999) Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med 159:1998-2002

Parad, R B (1998) Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement. Pediatrics 101:851-5

Parad, R B (1996) Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D. J Med Genet 33:711-3

Parad, R B; Applegate, K; Doubilet, P M et al. (1995) Occult fetal bowel obstruction: ileal atresia presenting in a newborn infant after normal antenatal sonography. J Ultrasound Med 14:161-3